$SPPI

Spectrum Pharmaceuticals Inc.

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$3.38 ▼-0.88%

Last Close

VOLUME

2,483,515

DAY RANGE

3.29 - 3.45

52 WEEK

1.74 - 10.57

Echofin Members Consensus

JC
jcarlgohn #StockTraders.NET Join team
recently

Algo long $FATE and $SPPI at 50.46 and 4.13

SO
soheil.n #StockTraders.NET Join team
recently

i waited too long for $sppi for a bounce that never came...seeing a trend recently some just don't bounce

profile
maletone #StockTraders.NET Join team
recently

yup i wanted $SPPI too

BR
brAli #StockTraders.NET Join team
recently

i reall wanted tht $sppi to pop HOD

Key Metrics

Market Cap

492.58 M

Beta

0.39

Avg. Volume

2.94 M

Shares Outstanding

145.73 M

Yield

0%

Public Float

143.18 M

Next Earnings Date

2020-11-04

Next Dividend Date

Company Information

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.

CEO: Joseph W. Turgeon

Website:

HQ: 11500 South Eastern Avenue Henderson, 89052 NV

Related News

  • OpenPR

    Neutropenia Treatment Market Top Key Players- Enzychem Lifesciences Corporation, Spectrum Pharmaceuticals, Inc., Tianjin SinoBiotech Ltd., S&D Pharma SK s.r.o., Samsung Medical Center Growth Trends, quantitative analysis Industry Analysis and Market Dynam

    27 Oct 2020, 11:17
  • Business Wire

    Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim)

    26 Oct 2020, 11:00
  • Benzinga

    Pfizer's COVID-19 Vaccine Candidate Primed For $3.5B In 2021 Sales: Analyst

    21 Oct 2020, 14:45
  • Business Wire

    Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September

    08 Sep 2020, 11:00
  • Business Wire

    Spectrum Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Corporate Update

    03 Aug 2020, 11:00